Trending News Today: Federal Officials Consider Passing DIR Fee Savings to Medicare Beneficiaries

A new study from the CDC and FDA indicated that 1 in 5 adults, or 49 million Americans, used tobacco in 2015, The New York Times reported. Of these individuals, 87% smoked cigarettes, cigars, or a pipe, while the remaining Americans used e-cigarettes or smokeless tobacco products. Additionally, 9.5 million Americans said that they used 2 or more tobacco products daily. These findings underscore the need for enhanced anti-tobacco efforts, according to the article.

Federal officials are considering a proposal that would allow Medicare beneficiaries to receive prescription drug discounts negotiated by insurers and pharmacy benefit managers, according to Kaiser Health News. Medicare beneficiaries have experienced high increases in out-of-pocket costs due to direct and indirect remuneration (DIR) fees. Proponents of the rule said sharing DIR fee discounts could reduce drug costs and reduce the number of patients accelerating into the Part D donut hole and catastrophic coverage, in which the government is responsible for paying a large majority of drug costs, according to the article.

Affordable Care Act (ACA) sign ups within the first few days of 2018 open enrollment significantly surpassed previous years, which may suggest the marketplace is not crashing, according to The New York Times. Of the 601,462 Americans who enrolled in ACA plans within the first 4 days, 23% were new customers, according to the article. This uptick in enrollment occurred despite attempts to repeal the health law and cuts to funding for outreach efforts.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

A look at last week's top stories in the world of pharmacy.
Michael Reff, RPh, MBA, explains how the National Community Oncology Dispensing Association champions for best practices with the use of CDK4/6 (cyclin-dependent kinases 4 and 6) inhibitors for patients with breast cancer.
Study examines whether markers of biological aging due to cancer treatment are related to cognitive function in survivors of breast cancer.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.